As the use of generative artificial intelligence becomes ubiquitous, it is critical for companies to learn to recognize and avoid common traps associated with AI. The hazards range from u...
On March 13, the European Parliament passed a draft of the Artificial Intelligence Act. The AI Act includes requirements for U.S. businesses using or developing AI systems or general-purp...
Davis Polk partners David Bauer and Matt Bacal, counsel Samantha Lefland and law clerk Ted Talas authored “Artificial intelligence in drug development” in the Legal 500: Life Sciences...
Webinar
1.0 CA - General; NY - Professional Practice / Practice Management
Davis Polk hosts a series of webinars focused on legal considerations for life sciences and healthcare companies. In this installment, senior lawyers discuss considerations and strategies...
On February 12, 2024, the United States Patent and Trademark Office issued inventorship guidance for AI-assisted inventions. The guidance follows caselaw establishing that an AI system c...
Generative artificial intelligence (generative AI) tools pose new risks to a company’s trade secrets. This client update describes three steps that companies should consider to protect ...
The Consumer Financial Protection Bureau (CFPB) proposed its long-awaited rule to implement Dodd-Frank Section 1033’s requirements regarding consumer rights to access financial informat...
Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi and partner Matthew Bacal authored the United States article in Financier Worldwide’s Intellectual Propert...
The final rules require current reporting of cybersecurity incidents and annual risk management disclosure for public companies that are likely to compound compliance costs and enforcemen...
Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi, partners Matt Bacal and Pri Shah, and associate Josh Shirley co-authored “Important Generative AI Conside...
